ABT - ABBOTT LABORATORIES


133.06
0.460   0.346%

Share volume: 6,180,798
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations: -0.13%

PREVIOUS CLOSE
CHG
CHG%

$132.60
0.46
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025
Fiscal Quarter Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Report Date 08-03-2023 11-01-2023 10-31-2024 05-02-2024 07-31-2024 10-31-2024 02-21-2025 04-30-2025
Total revenue 9.978 B 10.143 B 10.241 B 9.964 B 10.377 B 10.635 B 10.974 B 10.358 B
Cost of revenue 4.483 B 4.605 B 4.556 B 4.463 B 4.603 B 4.698 B 4.942 B 4.468 B
Gross profit 5.495 B 5.538 B 5.685 B 5.501 B 5.774 B 5.937 B 6.032 B 5.890 B
    0.78% 2.65% -3.24% 4.96% 2.82% 1.60% -2.35%  
Operating expenses 3.455 B 3.395 B 3.424 B 3.643 B 3.634 B 3.608 B 3.656 B 3.777 B
Selling general and admin 2.740 B 2.723 B 2.724 B 2.959 B 2.936 B 2.895 B 2.907 B 3.061 B
Research and development 715.000 M 672.000 M 700.000 M 684.000 M 698.000 M 713.000 M 749.000 M 716.000 M
Total expenses 3.953 B 3.891 B 3.905 B 4.115 B 4.105 B 4.078 B 4.121 B 4.197 B
    -1.57% 0.36% 5.38% -0.24% -0.66% 1.05% 1.84%  
Operating income 1.542 B 1.647 B 1.780 B 1.386 B 1.669 B 1.859 B 1.911 B 1.693 B
Ebit 1.697 B 1.740 B 1.865 B 1.497 B 1.665 B 1.991 B 2.075 B 1.827 B
Pretax income 1.636 B 1.671 B 1.795 B 1.436 B 1.607 B 1.940 B 2.030 B 1.778 B
    2.14% 7.42% -20.00% 11.91% 20.72% 4.64% -12.41%  
Income tax 261.000 M 235.000 M 201.000 M 211.000 M 305.000 M 294.000 M -7.199 B 453.000 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income 1.375 B 1.436 B 1.594 B 1.225 B 1.302 B 1.646 B 9.229 B 1.325 B
    4.44% 11.00% -23.15% 6.29% 26.42% 460.69% -85.64%